Diagnostic uses of snake venom

Haemostasis

Volumn 31, Issue 3-6, 2001, Pages 211-217

  Marsh, Neville A ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Coagulation assays; Disintegrins; Haemostasis; Platelet function tests; Snake venom thrombin like enzymes; Snake venom toxins

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BOTROCETIN; DISINTEGRIN; ENZYME; FIBRINOGEN; GLYCOPROTEIN RECEPTOR; HEPARIN; LECTIN; LUPUS ANTICOAGULANT; METALLOPROTEINASE; PROTEIN; PROTEIN C; PROTEIN PROTAC; PROTEIN STA STACLOT; PROTHROMBIN; RECEPTOR; SNAKE VENOM; THROMBIN; UNCLASSIFIED DRUG; VIPER VENOM; VON WILLEBRAND FACTOR; ANTICOAGULANT AGENT; COAGULATING AGENT; DIAGNOSTIC AGENT;

ARTICLE; AUSTRALIA; BLOOD CLOTTING; BLOOD DISEASE; BOTHROPS JARARACA; CONTROLLED STUDY; CROTALUS VIRIDIS HELLERI; DIAGNOSTIC PROCEDURE; DYSFIBRINOGENEMIA; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME INHIBITION; HEMOSTASIS; NONHUMAN; PRIORITY JOURNAL; SNAKE; TOXIN ANALYSIS; ANIMAL; BLOOD CLOTTING TEST; DRUG EFFECT; HUMAN; REVIEW;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION TESTS; COAGULANTS; HEMOSTASIS; HUMANS; SNAKE VENOMS;

EID: 0035742949     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048065     Document Type: Article

References (72)

1. Snake venoms affecting the haemostatic mechanism - A consideration of their mechanisms, practical applications and biological significance
2. Snake venoms
3. Snake venom proteins acting on hemostasis
4. Snake venom proteases affecting hemostasis and thrombosis
5. Thrombin-like enzymes from snake venoms: An updated inventory
6. Reptilase-R, a new reagent in blood coagulation
7. A method of antithrombin estimation using plasma defibrinated with ancrod
8. The haemostatic defect of chronic liver disease
9. Evaluation of reptilase-R and thrombin clotting time in the presence of fibrinogen degradation products and heparin
10. Fibrin assembly after fibrinopeptide A release in model systems and human plasma studied with magnetic birefringence
11. The influence of fibrinogen and fibrin on thrombin generation - Evidence for feedback activation of the clotting system by clot bound thrombin
12. Heparin ablates force development during platelet mediated clot retraction
13. A sensitive assay for tissue plasminogen activator
14. Structural and functional properties of snake venom prothrombin activators
15. The specific assay of prothrombin using the taipan snake venom
16. Isolation, biochemical and pharmacological characterization of a prothrombin activating principle from Echis carinatus venom
17. Ecarin test in diagnosis of dicoumarol therapy, liver diseases and DIC
18. Prothrombin Houston: A dysprothrombin identifiable by crossed immunoelectro-focussing and abnormal Echis carinatus venom activation
19. Purification and characterization of a variant of human prothrombin - Prothrombin Segovia
20. Significance of a prothrombin assay method using Echis carinatus venom for diagnostic information in disseminated intravascular coagulation syndrome
21. Mechanisms of α-thrombin and β-thrombin-E formation: Use of ecarin for isolation of meizothrombin 1
22. Meizothrombin, a major product of factor Xa-catalysed prothrombin activation
23. Calcium ion modulation of meizothrombin autolysis at Arg55-Asp56 and catalytic activity
24. Isolation and characterization of carinactivase, a novel prothrombin activator in Echis carinatus venom with a unique catalytic mechanism
25. Snake venom proteases that activate blood coagulation factor V
26. Thrombin-catalysed activation of recombinant human factor V
27. The Stuart-Prower assay and its clinical significance
28. Thromboplastin generation: Effect of the Bell-Alton reagent and Russell's viper venom on prothrombin consumption
29. The use of dilute Russell viper venom time for the diagnosis of lupus coagulants
30. The specific assay of Prower Stuart factor and factor VII
31. Differentiation of thrombin and factor Xa-related amidolytic activity in plasma by means of a synthetic thrombin inhibitor
32. Enzyme-linked coagulation assay. V. Amplified blotting assays using snake venom conjugates
33. Molecular recognition in the activation of human blood coagulation factor X
34. Identification of O-linked oligosaccharide chains in the activation peptides of blood coagulation factor X
35. Platelet aggregation and the availability of platelet factor 3
36. Platelet factor 3 in plasma fractions - Its relation to microparticle size and thromboses
37. Some recent developments with lupus anticoagulants
38. Laboratory identification of lupus anticoagulants - Results of the Second International Workshop for Identification of Lupus Anticoagulants
39. Sensitivity of the activated partial thromboplastin time, the dilute Russell's viper venom time, and the kaolin clotting time for the detection of the lupus anticoagulant: A direct comparison using plasma dilutions
40. A sensitive DRVVT reagent system for the detection of lupus anticoagulants
41. Improved detection of lupus anticoagulants by the dilute Russell's viper venom time
42. The taipan snake venom time: A new test for lupus anticoagulant
43. The textarin/ecarin ratio: A confirmatory test for lupus anticoagulants
44. Evaluation of recently described tests for the detection of the lupus anticoagulant
45. Purification of a protein C activator from the venom of the Southern copperhead snake (Agkistrodon contortrix contortrix)
46. Characterization of the protein C activator Protac® from the venom of the southern copperhead (Agkistrodon contortrix) snake
47. Protein C functional assay using snake venom activator
48. Practical application of the protein C activator Protac® from Agkistrodon contortrix venom
49. Fast functional protein C assay using Protac®, a novel protein C activator
50. Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicentre evaluation
51. Fast functional assay of protein C in whole plasma using a snake venom activator: Evaluation in patients with congenital and acquired protein C deficiencies
52. Functional assays of protein C: Comparison of two snake venom assays with two thrombin assays
53. Anticoagulant response to Agkistrodon contortrix venom (ACV test): A new global test to screen for defects in the anticoagulant protein C pathway
54. ++
55. Rapid amidolytic assay of protein C in whole plasma using an activator from the venom of Agkistrodon contortrix
56. Plasma protein S activity measured using Protac, a snake venom derived activator of protein C
57. Activation of recombinant human protein C
58. Mutation in blood coagulation factor V associated with resistance to activated protein C
59. Evaluation of a highly specific functional test for the detection of factor V Leiden
60. The use of two different APC resistance assay systems provides optimal sensitivity and specificity for diagnosing genetic APC resistance
61. APC-resistance as measured by a textarin time assay - Comparison to the APTT-based method
62. Different anticoagulant response to activated protein C (APC test) and to Agkistrodon contortrix venom (ACV test) in a family with FV-R506Q substitution
63. Venom co-agglutinin for detection on von Willebrand factor activity in animal plasmas
64. Botrocetin and von Willebrand factor
65. Progress in the clinical management of haemophilia
66. Inhibition assay for the binding of biotinylated von Willebrand factor to platelet-bound microtiter wells in the presence of ristocetin or botrocetin
67. Purification and characterization of human platelet von Willebrand factor
68. Von Willebrand disease type B: A missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib
69. Impaired high-shear-stress-induced platelet aggregation in patients with chronic renal failure undergoing dialysis
70. Characterization of snake venom components acting on blood coagulation and platelet function
71. Natural integrin antagonists from snake venoms: Ligand-specific inhibitors
72. Snake venom modulators of platelet adhesion receptors and their ligands